Drugs & medicalType I

Apo-Amitriptyline: Affected lots may exceed the interim acceptable intake limit for NNORT

Product safety

Read the official notice →
Date
2024-10-17
Country
Canada
Product
Apo-Amitriptyline
Classification
Type I
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2024-10-18
  2. CA
    Drugs & medicalType II

    CardioMEMS Patient Electronics System

    Performance

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType II

    Uropass Ureteral Access Sheath

    Performance

    Health CanadaOfficial notice →
  4. CA
    Drugs & medicalType I

    MiniMed 670 g, 780 g, 770 g and 630 g

    Performance

    Health CanadaOfficial notice →
  5. 2024-10-17
  6. CA
    Drugs & medicalType II

    Torontek-Pocket Fetal Doppler

    Labelling and packaging

    Health CanadaOfficial notice →
  7. CA
    Drugs & medicalType II

    Temporomandibular Joint (TMJ) Packs

    Sterility

    Health CanadaOfficial notice →
  8. 2024-10-16
  9. CA
    Drugs & medicalType II

    Electrosurgical Generator, ESG-410

    Performance

    Health CanadaOfficial notice →
See all drugs & medical recalls →